Gradient Investments LLC - CNS PHARMACEUTICALS INC ownership

CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102. A total of 10 filers reported holding CNS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Gradient Investments LLC ownership history of CNS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$02000.0%0.00%
Q2 2022$02000.0%0.00%
Q1 2022$02000.0%0.00%
Q4 2021$02000.0%0.00%
Q3 2021$02000.0%0.00%
Q2 2021$02000.0%0.00%
Q1 2021$02000.0%0.00%
Q4 2020$02000.0%0.00%
Q3 2020$02000.0%0.00%
Q2 2020$02000.0%0.00%
Q1 2020$0
-100.0%
2000.0%0.00%
Q4 2019$1,0002000.00%
Other shareholders
CNS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ESSEX INVESTMENT MANAGEMENT CO LLC 61,563$108,0000.02%
Integrated Advisors Network LLC 10,700$19,0000.00%
Alpha Cubed Investments, LLC 10,000$18,0000.00%
UBS Group AG 3,960$7,0000.00%
OSAIC HOLDINGS, INC. 5,000$9,0000.00%
WELLS FARGO & COMPANY/MN 41$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 12,500$22,0000.00%
SHINE INVESTMENT ADVISORY SERVICES INC 30$00.00%
Gradient Investments LLC 200$00.00%
View complete list of CNS PHARMACEUTICALS INC shareholders